Filing Details
- Accession Number:
- 0001104659-22-007441
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-25 17:01:17
- Reporting Period:
- 2022-01-24
- Accepted Time:
- 2022-01-25 17:01:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1722964 | Y-Mabs Therapeutics Inc. | YMAB | Pharmaceutical Preparations (2834) | 474619612 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1752940 | Bo Kruse | C/O Y-Mabs Therapeutics, Inc. 230 Park Avenue Suite 3350 New York NY 10169 | Evp, Cfo, Secretary & Treas. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-01-24 | 4,000 | $9.84 | 189,077 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2021.
Billionaire Hedge Funds
